InterpaceBiosciences_New Logo.png
Interpace Biosciences Terminates Rights Offering Announces Change in CMS Medicare Reimbursement of its Thyroid Tests
28. Januar 2022 19:35 ET | Interpace Biosciences, Inc.
PARSIPPANY, NJ, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”) a leader in enabling personalized medicine, announced today that it was...
ABT TO SUPPORT CMS Q
ABT TO SUPPORT CMS QUALITY PAYMENT PROGRAM FOR MEDICARE PROVIDERS
31. Oktober 2019 09:47 ET | Abt Associates
Rockville, Md., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Through a new contract, Abt Associates will continue to support the Centers for Medicare & Medicaid Services’ (CMS) efforts to incentivize...
logo.jpg
RENNOVA HEALTH GIVES UPDATE ON SECOND QUARTER
12. Juli 2018 09:20 ET | Rennova Health, Inc.
WEST PALM BEACH, Fla, July 12, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTCQB: RNVA), (OTCQB: RNVAW), (“Rennova” or the “Company”), a vertically integrated provider of industry-leading...
Joint Commission Res
Joint Commission Resources Awarded Funds to Improve Hospital Care and Patient Safety
15. Dezember 2011 15:46 ET | The Joint Commission
OAK BROOK, IL--(Marketwire - Dec 15, 2011) - Joint Commission Resources (JCR) is one of 26 leading health care organizations that will work with hospitals to make health care safer and less costly...